THESSALIANemolizumabSystemic sclerosis (SSc)SSc-associated interstitial lung disease
…ry fibrosis in SSc-associated interstitial lung disease.Methods THESSALIA ( NCT07047690) is a phase II, randomised, double-blind, placebo…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…ry fibrosis in SSc-associated interstitial lung disease.Methods THESSALIA ( NCT07047690) is a phase II, randomised, double-blind, placebo…